The Last Word On Drug Preemption?
Many prognosticators expect the Supreme Court to rule that the Food and Drug Administration's approval of a prescription drug preempts certain state-law tort claims.
But there is less consensus about the likely scope of the court's ruling: Will it put an end to pharmaceutical mass-tort litigation as we know it? Or will it stay...
To view the full article, register now.